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TECHNICAL NOTE
The prevention of postoperative paraplegia and
paraparesis after the repair of thoracoabdominal aor-
tic aneurysms (TAAAs) remains a major focus of
investigation. Recent clinical data1-3 support the use
of distal aortic perfusion by bypass from the left atri-
um to the femoral artery or distal aorta as an adjunct
to prevent spinal cord ischemia and subsequent neu-
rologic deficits during graft replacement of extensive
TAAAs (Crawford4 extents I and II). Previously, we
and others3,5-8 have reported using an indirect-drive
centrifugal pump (Bio-Medicus BP-80, Eden
Prairie, Minn.) for atriodistal bypass (ADB) during
TAAA repair.
The Nikkiso HMS-12 pump (HIMEX Produc-
tion Co., Inc., Houston, Tex.) is a compact, atrau-
matic, direct-drive centrifugal pump developed in
our department and recently approved for clinical
use.9 Excellent results have been described with the
Nikkiso pump for cardiopulmonary bypass proce-
dures.10-12 The use of this new pump for ADB dur-
ing TAAA surgery, however, has not yet been
reported. The purpose of this report is to describe
our initial clinical experience with the Nikkiso pump
for ADB during repair of extensive TAAAs.
PATIENTS AND METHODS
Between December 21, 1995, and February 6,
1996, the Nikkiso HMS-12 centrifugal pump was
used for ADB perfusion during graft repair of exten-
sive TAAAs in 10 consecutive patients. The median
age was 70.5 years (range, 51 to 74 years). Seven
men and three women were evaluated. Six patients
had extent I TAAAs, and four had extent II TAAAs.
Two patients had aortic dissection (one chronic and
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one acute with progressive symptoms), and eight
patients had chronic nonspecific aneurysms without
dissection. No patient had a ruptured aneurysm.
Significant preoperative risk factors included hyper-
tension in five patients, chronic obstructive pul-
monary disease in four patients, ischemic heart dis-
ease in four patients, history of smoking in four
patients, renal stenosis documented with angiogra-
phy in two patients, and evidence of cerebral vascu-
lar occlusive disease in two patients. One patient
with chronic ischemic cardiomyopathy had extreme-
ly poor left ventricular function with an ejection frac-
tion of 18% determined by preoperative echocardio-
graphy. Previous operations included abdominal aor-
tic aneurysm repair in one patient, coronary artery
bypass and abdominal aortic aneurysm repair in one
patient, and replacement of the aortic valve and
ascending aorta with coronary artery bypass in one
patient.
The bypass circuit consisted of inflow and out-
flow cannulas, 3/8-inch polyvinylchloride tubing,
and the Nikkiso centrifugal pump. The pumphead
(Fig. 1) has an impeller diameter of 50 mm, a prim-
ing volume of 25 ml, and a weight of 145 gm. Six
small holes in the impeller prevent stagnation of
blood to help reduce thrombosis. The pump was
placed remotely from the driver console with a flex-
ible shaft that allowed placement of the pump close
to the surgical field. No blood reservoir, heat
exchanger, or oxygenator was incorporated in the
circuit. The total priming volume of the circuit was
720 ml. For selective visceral or renal perfusion, bal-
loon perfusion catheters were connected to the out-
flow limb with a three-way stopcock (Fig. 2). By
clamping the outflow tube, selective visceral or renal
bypass from the left atrium was achieved.
The surgical technique, standardized by the
author performing all operations (J. S. C.), has been
recently described in detail.13-15 All patients under-
went intubation with a double-lumen endotracheal
tube to permit deflation of the left lung. The
patients were placed in an oblique, lateral decubitus
position with the pelvis rotated to the left to allow
access to the femoral arteries. Exposure of the aorta
was achieved with a left thoracoabdominal incision
through the sixth intercostal space and a transperi-
toneal approach with medial visceral rotation. The
inflow cannula, a no. 26 USCI aortic cannula (C.R.
Bard, Inc., Tewksberry, Mass.), was inserted into the
left atrium and secured with a purse string suture.
An 18F to 22F outflow cannula was inserted into
the aneurysmal mid-descending thoracic aorta in
nine cases and the left common femoral artery in
one case; we currently favor the former insertion site
because it eliminates the complications associated
with femoral artery cannulation. After mild systemic
heparinization (1 mg/kg) was performed, ADB was
initiated at 500 ml/min, and the proximal aorta was
clamped. Flow rates were adjusted to maintain mean
distal aortic pressures near 70 mm Hg and mean
pulmonary arterial pressures near 20 mm Hg; these
parameters are generally achieved at flow rates
between 1500 and 2500 ml/min. Sodium nitro-
prusside was used in conjunction with ADP to main-
tain normal proximal arterial pressures. The
descending aorta was then clamped at a level above
the critical intercostal arteries, and the proximal por-
tion of the aneurysm was opened (Fig. 3, A). A cell-
saving blood collection system was used to return
shed blood to the patient. A woven Dacron tube was
used for graft replacement in all cases. After the
proximal anastomosis was completed, ADB was dis-
continued, and the distal aortic clamp was removed.
The remainder of the aneurysm was then opened to
its distal extent. In the four patients who had
aneurysms involving the entire thoracoabdominal
Fig. 1. Nikkiso centrifugal pumphead.
Fig. 2. Atriodistal bypass circuit including Nikkiso centrifugal
pumphead, inflow and outflow cannulas, and visceral/renal per-
fusion catheters.
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Fig. 3. Technique of distal perfusion during extent II thoracoabdominal aortic aneurysm repair. Atriodistal bypass is used during initial
aortic clamping (A) and performance of proximal anastomosis. Selective visceral and renal perfusion with balloon cannulas is used dur-
ing reattachment of critical intercostal arteries (B). During reattachment of visceral vessels (C), selective visceral and renal perfusion con-
tinues while intercostal arteries, now proximal to distal clamp, receive antegrade perfusion.
aorta (extent II), balloon cannulas were inserted
into the origins of the celiac axis, superior mesen-
teric artery, and both renal arteries; selective renal
and visceral perfusion was then performed by
occluding the outflow tubing and resuming pump
flow (Fig. 3, B). Critical intercostal arteries were
then attached to the graft as an island in nine
patients. The visceral and renal arteries were reat-
tached with either a beveled distal anastomosis
(extent I) or Carrel patch (extent II, Fig. 3, C). After
the visceral and renal vessels were reattached in
extent II repairs, the balloon cannulas were
removed, the graft was flushed, and the distal clamp
was moved below the visceral arteries, thereby
resuming antegrade perfusion during completion of
the distal anastomosis.
RESULTS
All patients underwent ADB without mechanical
pump malfunction or adverse events related to the
device. The mean total aortic clamp time was 49.6 ±
8.0 minutes, and mean spinal ischemic and viscer-
al/renal ischemic times were 24.3 ± 4.8 minutes and
18.4 ± 5.8 minutes, respectively. The average flow
rates for distal aortic perfusion and selective visceral
or renal perfusion were 2.4 ± 0.6 L/min and 330 ±
30 ml/min, respectively.
No perioperative deaths occurred. No patient
had paraplegia after surgery. Two patients had tem-
porary delayed lower extremity weakness after
undergoing extent I TAAA repairs; one patient had
transient left leg weakness with associated urinary
retention on postoperative day 1 and was walking
without assistance at the time of discharge, and the
second patient had paraparesis on postoperative day
2, responded to treatment that included mannitol
and steroids, and was also ambulatory at the time of
discharge. Postoperative renal function was main-
tained within normal range in all patients; the aver-
age maximum postoperative serum creatinine level
was 1.2 ± 0.3 mg/dl. No patient had coagulopathy
or required reexploration because of bleeding. Two
patients had left vocal cord paralysis and were suc-
cessfully treated with type I thyroplasty.16 Two
patients had bradyarrythmias and required pacemak-
er implants. No complications were associated with
cerebral, respiratory, or hepatic function. All patients
were discharged from the hospital; the average dura-
tion of hospital stay was 14.7 ± 3.1 days.
DISCUSSION
Patients with extensive TAAAs (extents I and II)
are at greatest risk for having ischemic complications
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of the spinal cord caused by inherently prolonged
aortic cross-clamp times.17,18 Although several
investigators advocate various adjunctive methods
such as cerebrospinal fluid drainage,3,19 epidural
cooling,20 profound hypothermic circulatory
arrest,21,22 and intraoperative monitoring of spinal
evoked potentials,23 the effectiveness of these meth-
ods remains controversial.24-26 Our current
approach to spinal cord protection includes moder-
ate heparinization, permissive hypothermia, selective
use of ADB, and aggressive reattachment of critical
intercostal arteries (T8 to L1). We do not use cere-
brospinal fluid drainage. As previously reported, the
use of ADB during extensive TAAA repairs reduces
intercostal arterial ischemic time and reduces the
incidence of spinal cord injury.1-3,5,27 The two cases
of delayed lower extremity weakness that occurred
in this series were most likely caused by transient
postoperative hypoperfusion of the spinal cord
rather than intraoperative ischemia.28
Recent data suggest that ADB may also provide
renal protection during TAAA repair. A 1989 retro-
spective appraisal of Crawford’s series, by Svensson
et al.,29 did not show such a benefit. Although uni-
variate analysis of their complete experience with
1509 patients undergoing TAAA repair demonstrat-
ed a 13% incidence of renal failure when distal per-
fusion was used compared with 19% without ADB (p
= 0.032), multivariate analysis did not identify ADB
as a protective factor.17 The recent report from Safi
et al.,30 however, demonstrated that the use of ADB,
when used without selective visceral perfusion, was
associated with a decreased incidence of acute renal
failure after descending thoracic and TAAA repair,
whereas the use of simple clamping without perfu-
sion adjuncts was an independent predictor of post-
operative renal complications. Their finding that
selective visceral or renal perfusion had a detrimen-
tal effect on renal function is difficult to explain but
may be related to endothelial damage of the renal
arteries during catheter placement or balloon infla-
tion.
Mesenteric perfusion with ADB and selective
perfusion may have several beneficial effects. Media-
tors released during intestinal ischemia and reperfu-
sion have been implicated in the subsequent devel-
opment of multiple organ failure.31 Intestinal
ischemia and reperfusion injury may also adversely
affect renal perfusion and function.32 Furthermore,
animal studies by Cohen et al.33-35 and clinical data
from Illig et al.36 have demonstrated an association
between visceral ischemia and coagulopathy after
supraceliac aortic cross-clamping. Therefore the
reduced visceral ischemic times provided by ADB
may reduce the risks of organ failure and bleeding
complications. Additional studies are required to
further evaluate these potential benefits of ADB.
By unloading the proximal circulation, ADB may
also provide cardiac and cerebral protection during
aortic cross-clamping.37 Our patient with a left ven-
tricular ejection fraction of 18% tolerated repair of
an extent II TAAA without perioperative cardiac
complications, and no patient had perioperative
cerebrovascular complications.
The original ADB circuits used roller pumps.38
Centrifugal pumps, introduced 20 years ago, offer
several improvements over the roller pumps: less
setup time, lower priming volumes, decreased
hemolysis, and reduced risk of air embolism.10,39
Most current reports on ADB describe the use of the
Bio-Medicus centrifugal pump, which uses an indi-
rect-drive system with a magnetically coupled
impeller-rotor.2,5-8,37,40,41
The perfusion system introduced in this study is
simple and small, with a compact centrifugal pump.
The Nikkiso pump, with a priming volume of 25 ml
(vs 80 ml, Bio-Medicus) and weight of 145 gm (vs
280 gm, Bio-Medicus), is the smallest and lightest
commercially available centrifugal pump.11,12,39 The
use of a flexible shaft permits placement of the
Nikkiso pumphead close to the surgical table, there-
by further decreasing the total system priming vol-
ume. The lack of a heat exchanger in the circuit
allows permissive mild hypothermia, providing addi-
tional spinal cord protection.13,21,22,24 We do not
use an oxygenator during ADB, as described by
Aomi et al.8 Although the Nikkiso ADB system does
not require heparin at flow rates greater than 1.5
L/min, we use moderate heparinization to prevent
thrombosis of vessels supplying the spinal cord. In
terms of hemolysis, in vitro and in vivo stud-
ies11,39,42,43 have demonstrated that the Nikkiso
pump compares favorably and may be superior to
both roller pumps and other commercially available
centrifugal pumps including the Bio-Medicus
model. The antithrombogenic nature of the Nikkiso
pump has also been confirmed.9,42
ADP is also being used for spinal cord protection
during repair of traumatic descending thoracic aor-
tic rupture.44 The characteristics of the Nikkiso
ADB circuit such as the ease of air removal and low
priming volume, which allow it to be primed quick-
ly,11 make this system ideal for these often urgent
trauma cases.
In summary, our initial experience with the
Nikkiso centrifugal pump during TAAA repair
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demonstrated excellent pump function without
adverse mechanical events. Despite its small design,
the Nikkiso pump provided sufficient flow for both
distal aortic and selective organ perfusion. The pre-
vention of permanent spinal cord injury and distal
organ failure was successful in this small group. A
larger prospective trial comparing the Nikkiso pump
with currently accepted devices (i.e., the Bio-
Medicus pump) is a logical next step in confirming
the safety and effectiveness of this newer pump in
the setting of TAAA surgery.
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